Cargando…

N(6)-methyladenosine (m(6)A) RNA methylation signature as a predictor of stomach adenocarcinoma outcomes and its association with immune checkpoint molecules

OBJECTIVE: Although N(6)-methyladenosine (m(6)A) RNA methylation is the most common mRNA modification process, few studies have examined the role of m(6)A in stomach adenocarcinomas (STADs). METHODS: In this retrospective study, we analyzed 293 STAD samples from The Cancer Genome Atlas with complete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mo, Pingfan, Xie, Siyuan, Cai, Wen, Ruan, Jingjing, Du, Qin, Ye, Jun, Mao, Jianshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Retrospective Clinical Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522833/ https://www.ncbi.nlm.nih.gov/pubmed/32972288 http://dx.doi.org/10.1177/0300060520951405

Ejemplares similares

Tumor-Infiltrating Lymphocyte-Based Risk Score for Predicting Prognosis in Gastric Cancer
por: Xie, Siyuan, et al.
Publicado: (2020)

Deciphering N(6)-Methyladenosine-Related Genes Signature to Predict Survival in Lung Adenocarcinoma
por: Zhu, Jie, et al.
Publicado: (2020)

N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinoma
por: Xu, Hao, et al.
Publicado: (2022)

N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma
por: Meijing, Zhang, et al.
Publicado: (2022)

METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma
por: Zhang, Zhijin, et al.
Publicado: (2023)

Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy
por: Zhou, Xianyong, et al.
Publicado: (2023)

The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma
por: Yao, Qi, et al.
Publicado: (2021)

Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma
por: Zhang, Lemeng, et al.
Publicado: (2021)

Analysis of N(6)-Methyladenosine Methylome in Adenocarcinoma of Esophagogastric Junction
por: Huang, Jia-Bin, et al.
Publicado: (2022)

Biomarkers Associated with Immune Checkpoint, N6-Methyladenosine, and Ferroptosis in Patients with Restenosis
por: Tong, Xiao, et al.
Publicado: (2023)

A Signature Based on Costimulatory Molecules for the Assessment of Prognosis and Immune Characteristics in Patients With Stomach Adenocarcinoma
por: Chen, Bangjie, et al.
Publicado: (2022)

Genomics and Prognosis Analysis of N(6)-Methyladenosine Regulators in Lung Adenocarcinoma
por: Ma, Yanpin, et al.
Publicado: (2021)

N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma
por: Zhao, Yibin, et al.
Publicado: (2022)

N6-methyladenosine methylation in kidney injury
por: Wang, Qimeng, et al.
Publicado: (2023)

An N6-Methyladenosine-Related Gene Set Variation Score as a Prognostic Tool for Lung Adenocarcinoma
por: Zhang, Huijuan, et al.
Publicado: (2021)

Construction and validation of an N6-methyladenosine-associated prognostic signature in hepatocellular carcinoma
por: Zhu, Peng, et al.
Publicado: (2021)

Application of side-to-side anastomosis of the lesser curvature of stomach and jejunum in gastric bypass
por: Bai, Ri-Xing, et al.
Publicado: (2016)

The roles of RNA N(6)-methyladenosine in esophageal cancer
por: Teng, Chuan, et al.
Publicado: (2022)

Establishment of Prognostic Signatures of N6-Methyladenosine-Related lncRNAs and Their Potential Functions in Hepatocellular Carcinoma Patients
por: Wu, Xianbin, et al.
Publicado: (2022)

Connecting N6‐methyladenosine modification to ferroptosis resistance in hepatoblastoma
por: Peng, Wan‐Xin, et al.
Publicado: (2022)

Signatures and Prognostic Values of N6-methyladenosine (m6A) - related Immune Genes in Bladder Cancer
por: Lin, Gaoteng, et al.
Publicado: (2021)

Effect of N6-methyladenosine methylation-related gene signature for predicting the prognosis of hepatocellular carcinoma patients
por: Zheng, Xinyu, et al.
Publicado: (2023)

N6-Methyladenosine RNA Methylation in Cardiovascular Diseases
por: Liu, Chi, et al.
Publicado: (2022)

A Ten-N(6)-Methyladenosine (m(6)A)-Modified Gene Signature Based on a Risk Score System Predicts Patient Prognosis in Rectum Adenocarcinoma
por: Huang, Wei, et al.
Publicado: (2021)

Gene Signatures and Prognostic Values of N6-Methyladenosine Related Genes in Ovarian Cancer
por: Na, Zhijing, et al.
Publicado: (2021)

Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
por: Chen, Yujia, et al.
Publicado: (2022)

N(6)-methyladenosine (m(6)A) methylation in ischemia–reperfusion injury
por: Yao, Weifeng, et al.
Publicado: (2020)

N6-methyladenosine RNA modification: an emerging molecule in type 2 diabetes metabolism
por: Zhang, Haocheng, et al.
Publicado: (2023)

The YTH Domain Family of N6-Methyladenosine “Readers” in the Diagnosis and Prognosis of Colonic Adenocarcinoma
por: Xu, Dian, et al.
Publicado: (2020)

Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma
por: Liu, Yong, et al.
Publicado: (2022)

Effects of N6-Methyladenosine Regulators on LAG3 and Immune Infiltrates in Lung Adenocarcinoma
por: Wang, Nengchao, et al.
Publicado: (2022)

N (6)-methyladenosine RNA methylation: From regulatory mechanisms to potential clinical applications
por: Li, Peipei, et al.
Publicado: (2022)

Acute Catarrh of the Stomach
Publicado: (1890)

A True Stomachic
Publicado: (1890)

N(6)-Methyladenosine and Viral Infection
por: Dang, Wei, et al.
Publicado: (2019)

Integrated Analyses of m6A Regulator-Based Signature on Its Clinical Application and Immunogenomic Landscape in Stomach Adenocarcinoma
por: Zhang, Lan, et al.
Publicado: (2022)

The N6-Methyladenosine- (m6A-) Associated Genes Act as Strong Key Biomarkers for the Prognosis of Pancreatic Adenocarcinoma
por: Li, Fei, et al.
Publicado: (2021)

Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma
por: Yuan, Qihang, et al.
Publicado: (2021)

Divest Yourself of a Preconceived Idea: Transcription Factor ATF6 Is Not a Soluble Protein!
por: Mori, Kazutoshi
Publicado: (2010)

circRNA N6-methyladenosine methylation in preeclampsia and the potential role of N6-methyladenosine-modified circPAPPA2 in trophoblast invasion
por: Zhang, Yonggang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_24k4pndkljbfn5kj6jnd1mi3jb